China Resources Double-Crane Pharmaceutical Co.,Ltd.
600062
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Category
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.23 | -0.96% |
| 2025 | $0.23 | 4.99% |
| 2024 | $0.22 | -5.99% |
| 2023 | $0.23 | 39.32% |
| 2022 | $0.17 | 16.74% |
| 2021 | $0.14 | -3.67% |
| 2020 | $0.15 | 1.38% |
| 2019 | $0.15 | 7.25% |
| 2018 | $0.14 | 8.59% |
| 2017 | $0.12 | 27.17% |
| 2016 | $0.10 | 0.93% |
| 2015 | $0.10 | -15.36% |
| 2014 | $0.11 | -34.44% |
| 2013 | $0.17 | 45.30% |
| 2012 | $0.12 | 18.52% |
| 2011 | $0.10 | 6.39% |
| 2010 | $0.10 | 18.36% |
| 2009 | $0.08 | 15.97% |
| 2008 | $0.07 | -11.58% |
| 2007 | $0.08 | 178.72% |
| 2006 | $0.03 | -6.62% |
| 2005 | $0.03 | 4,214.29% |
| 2004 | 0.00 | -93.00% |
| 2003 | $0.01 | -62.41% |
| 2002 | $0.03 | 9.92% |
| 2001 | $0.02 | 25.39% |
| 2000 | $0.02 | 0.00% |
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | 2,547.01% |
DE
|
|
| $6.01 | 2,537.31% |
DE
|
|
| $1.53 | 572.91% |
JP
|
|
| $3.66 | 1,506.67% |
CH
|
|
| $0.45 | 97.54% |
IL
|
Questions about China Resources Double-Crane Pharmaceutical Co.,Ltd.'s earnings per share (EPS)
What is China Resources Double-Crane Pharmaceutical Co.,Ltd.'s earnings per share (EPS)?
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s earnings per share (EPS) over the last twelve months is $0.23, as of Sep 2026.
What was China Resources Double-Crane Pharmaceutical Co.,Ltd.'s earnings per share (EPS) in 2025?
In 2025, China Resources Double-Crane Pharmaceutical Co.,Ltd.'s earnings per share (EPS) was $0.23, 4.55% more than in 2024 ($0.22).
How has China Resources Double-Crane Pharmaceutical Co.,Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, China Resources Double-Crane Pharmaceutical Co.,Ltd.'s earnings per share (EPS) went from $0.15 to $0.23, an average growth of 8.92% a year.
How does China Resources Double-Crane Pharmaceutical Co.,Ltd.'s earnings per share (EPS) compare with similar companies?
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s earnings per share (EPS) ($0.23) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.